$ Value
$1.6M
Shares
17,840
Price
$89
Filed
Dec 1
Insider
Name
LAUDER JANE
Title
—
CIK
0001008091
Roles
Transaction Details
Transaction Date
2025-11-26
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. | Sales prices range from $94.35 to $94.52 per share, inclusive. | Stock options granted pursuant to Amended and Restated Fiscal 2002 Share Incentive Plan in respect of: 5,946 shares exercisable from and after January 1, 2018; 5,947 shares exercisable from and after January 1, 2019; and 5,947 shares exercisable from and after January 1, 2020.
Filing Info
LAUDER JANE's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-15 | EB | A | $0 |
| 2025-12-15 | EL | A | $274 |
| 2025-11-26 | EL | M | $1.6M |
| 2025-11-26 | EL | ▼ | $1.7M |
| 2025-11-26 | EL | M | $1.6M |
| 2025-11-13 | EL | A | $0 |
| 2025-11-13 | EL | A | $0 |
| 2025-10-15 | EB | A | $0 |
| 2025-08-21 | EL | M | $1.2M |
| 2025-08-21 | EL | ▼ | $1.4M |
Other Insiders at EL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
LAUDER RONALD S
Chairman, Clinique Labs, LLC
|
— | — | 2026-04-08 |
| LAUDER AERIN | — | — | 2026-04-08 |